Evaluating medical effectiveness for the California health benefits review program

Health Services Research

Volumn 41, Issue 3 II, 2006, Pages 1007-1026

  Luft, Harold S ^a   Rappaport, Karen M ^a   Yelin, Edward H ^a   Aubry, Wade M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

California Health Benefits Review Program; Case control studies; Efficacy; Mandate review; Medical effectiveness; Meta analyses; Observational studies; Randomized controlled trials; Systematic reviews

Indexed keywords

CALIFORNIA HEALTH BENEFITS REVIEW PROGRAM; DECISION MAKING; HEALTH INSURANCE; HEALTH PROGRAM; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL LITERATURE; PRACTICE GUIDELINE; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; VALIDATION PROCESS;

CALIFORNIA; EVALUATION STUDIES; HUMANS; INSURANCE BENEFITS; INSURANCE, HEALTH; MANDATORY PROGRAMS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 33646677217     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2006.00517.x     Document Type: Review

References (12)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR®). Arlington, VA : American Psychiatric Association.
2. Black, N. 1996 Why We Need Observational Studies to Evaluate the Effectiveness of Health Care British Medical Journal 312 7040 : 1215 8.
3. California Health Benefits Review Program. 2005a. "About CHBRP" [accessed on August 1, 2005]. Available at
4. California Health Benefits Review Program. 2005b. "California Health Benefits Review Program Analyses" [accessed on June 20, 2005]. Available at
5. California Health and Safety Code. 2005. "HEALTH AND SAFETY CODE SECTION 127660-127665" [accessed on June 20, 2005]. Available at
6. D'Agostino, R. B. H. Kwan. 1995 Measuring Effectiveness Medical Care 33 4, Suppl : AS95 105.
7. Des Jarlais, D. C., C. Lyles N. Crepaz. 2004 Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions : The TREND Statement American Journal of Public Health 94 3 : 361 6.
8. Dieppe, P., C. Bartlett, P. Davey, L. Doyal S. Ebrahim. 2004 Balancing Benefits and Harms : The Example of Non-Steroidal Anti-Inflammatory Drugs British Medical Journal 329 7456 : 31 4.
9. Holtzman, N. A. 1992 The Diffusion of New Genetic Tests for Predicting Disease FASEB Journal 6 10 : 2806 12.
10. Kunz, R. A. D. Oxman. 1998 The Unpredictability Paradox : Review of Empirical Comparisons of Randomised and Non-Randomised Clinical Trials British Medical Journal 317 7167 : 1185 90.
11. MacLehose, R. R., B. C. Reeves, I. M. Harvey, T. A. Sheldon, I. T. Russell A. M. Black. 2000 A Systematic Review of Comparisons of Effect Sizes Derived from Randomised and Non-Randomised Studies Health Technology Assessment 4 34 : 1 154.
12. Victora, C. G., J. P. Habicht J. Bryce. 2004 Evidence-Based Public Health : Moving beyond Randomized Trials American Journal of Public Health 94 3 : 400 5.